These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 25502291

  • 1. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
    Li X, Zheng J, Chen L, Diao H, Liu Y.
    Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
    [Abstract] [Full Text] [Related]

  • 2. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G, Terrenato I, Spagnuolo M, Carosi M, Cognetti G, Cicchillitti L, Sperati F, Villani V, Carapella C, Piaggio G, Pelosi A, Rizzo MG.
    J Exp Clin Cancer Res; 2016 Jul 30; 35(1):124. PubMed ID: 27476114
    [Abstract] [Full Text] [Related]

  • 3. Decreased expression of microRNA-107 predicts poorer prognosis in glioma.
    Ji Y, Wei Y, Wang J, Ao Q, Gong K, Zuo H.
    Tumour Biol; 2015 Jun 30; 36(6):4461-6. PubMed ID: 25596705
    [Abstract] [Full Text] [Related]

  • 4. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
    Li B, Wang Y, Li S, He H, Sun F, Wang C, Lu Y, Wang X, Tao B.
    Int J Clin Exp Pathol; 2015 Jun 30; 8(6):7016-21. PubMed ID: 26261592
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of miR-770 indicates a favorable prognosis and suppresses tumorigenesis by modulating PI3K-AKT pathway in glioma.
    Feng FQ, Liu GS, Li JC, Chen LZ.
    Eur Rev Med Pharmacol Sci; 2019 Apr 30; 23(7):2870-2879. PubMed ID: 31002138
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
    Lai NS, Dong QS, Ding H, Miao ZL, Lin YC.
    J Clin Neurosci; 2014 May 30; 21(5):755-60. PubMed ID: 24382515
    [Abstract] [Full Text] [Related]

  • 7. Upregulation of miR-183 expression and its clinical significance in human brain glioma.
    Ye Z, Zhang Z, Wu L, Liu C, Chen Q, Liu J, Wang X, Zhuang Z, Li W, Xu S, Hang C.
    Neurol Sci; 2016 Aug 30; 37(8):1341-7. PubMed ID: 27215622
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T, Liu P, Chen L, Chen Z, Luo Y, Chen X, Feng Y, Luo X.
    Clin Transl Oncol; 2015 Jul 30; 17(7):504-10. PubMed ID: 25575767
    [Abstract] [Full Text] [Related]

  • 9. Association between downexpression of miR-1301 and poor prognosis in patients with glioma.
    Bai QL, Hu CW, Wang XR, Yin GF, Shang JX.
    Eur Rev Med Pharmacol Sci; 2017 Oct 30; 21(19):4298-4303. PubMed ID: 29077167
    [Abstract] [Full Text] [Related]

  • 10. Correlation of microRNA-10b upregulation and poor prognosis in human gliomas.
    Ji Y, Wei Y, Wang J, Gong K, Zhang Y, Zuo H.
    Tumour Biol; 2015 Aug 30; 36(8):6249-54. PubMed ID: 25773393
    [Abstract] [Full Text] [Related]

  • 11. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
    Guan Y, Chen L, Bao Y, Qiu B, Pang C, Cui R, Wang Y.
    Int J Clin Exp Pathol; 2015 Aug 30; 8(6):6576-88. PubMed ID: 26261539
    [Abstract] [Full Text] [Related]

  • 12. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ, Sun W, Wang Y, Li D, Hu AM.
    Eur Rev Med Pharmacol Sci; 2019 Jan 30; 23(1):271-276. PubMed ID: 30657585
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X, Lan F, Hu M, Pan Q, Wang Q, Wang J.
    J Neurosurg; 2016 Jan 30; 124(1):122-8. PubMed ID: 26230475
    [Abstract] [Full Text] [Related]

  • 14. Expression of microRNA-218 and its clinicopathological and prognostic significance in human glioma cases.
    Cheng MW, Wang LL, Hu GY.
    Asian Pac J Cancer Prev; 2015 Jan 30; 16(5):1839-43. PubMed ID: 25773834
    [Abstract] [Full Text] [Related]

  • 15. Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis.
    Wei X, Chen D, Lv T, Li G, Qu S.
    Mol Neurobiol; 2016 Jan 30; 53(1):163-170. PubMed ID: 25416859
    [Abstract] [Full Text] [Related]

  • 16. MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.
    Tong YQ, Liu B, Zheng HY, Gu J, Liu H, Li F, Tan BH, Hartman M, Song C, Li Y.
    Oncotarget; 2015 Sep 22; 6(28):25024-33. PubMed ID: 26317904
    [Abstract] [Full Text] [Related]

  • 17. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C, Guan Y, Zhao K, Chen L, Bao Y, Cui R, Li G, Wang Y.
    Int J Clin Exp Pathol; 2015 Sep 22; 8(5):4943-52. PubMed ID: 26191187
    [Abstract] [Full Text] [Related]

  • 18. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H, Yu L, Liu J, Bian X, Shi C, Sun C, Zhou X, Wen Y, Hua D, Zhao S, Ren L, An T, Luo W, Wang Q, Yu S.
    Oncotarget; 2017 Mar 21; 8(12):19723-19737. PubMed ID: 28160566
    [Abstract] [Full Text] [Related]

  • 19. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
    Feng F, Kuai D, Wang H, Li T, Miao W, Liu Y, Fan Y.
    Hum Pathol; 2016 Dec 21; 58():47-53. PubMed ID: 27569294
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
    Zhang J, Lv J, Zhang F, Che H, Liao Q, Huang W, Li S, Li Y.
    J Neurooncol; 2017 Jul 21; 133(3):553-559. PubMed ID: 28551850
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.